Advanced search

Herve Hoppenot holds the position of Chairman, President & Chief Executive Officer of Incyte Corp. He is also on the board of Biotechnology Innovation Organization, Cellectis SA and Pharmaceutical Research & Manufacturers of America. In his past career he was President at Novartis Oncology, Inc., President for Novartis Pharmaceuticals Corp., Head-US Oncology Business Unit at Aventis SA, Vice President-Oncology Division at Aventis Pharmaceuticals, Inc., Principal at Rhone Poulenc AG, Inc. and Head-US Oncology Business Unit at Rhone-Poulenc Rorer Pharmaceuticals, Inc.

Axel Hoppenot worked as an Executive VP-Sales & Marketing at Monte-Carlo Société des Bains de Mer SA from 2004 to 2021.

Mr. David Hoppenot is a Co-Founder & Special Advisor at Atalante SAS where he joined in 2004.
Mr. Hoppenot also served on the board at Adverline SA, Opteven Assurances SA and Utram SA. He received his undergraduate degree from Essca Ecole De Management and a graduate degree from Escp Business School.

Patrice Hoppenot is currently the Chairman at I&P Développement.
He was previously an Independent Director at Sperian Protection SAS in 2010, a Director at Burelle SA from 2005 to 2011, and a Director at Burelle Participations SA.